Back to mobile site

More on UNCY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+62.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Unicycive Therapeutics, Inc (NQ:UNCY)
Delayed: 5.28 --0 (-0%)
Prev. Close $5.28  
Open$5.28 
52 Wk High$ 
52 Wk Low$ 
Day High$5.28 
Day Low$5.28 
P/E N/A  
EPS$ 
Volume25,121 

Friends, Peers and Foes (?): FIVE, HUM, MOH, SLNO, APLT (more...)

Jul 1, 2026 05:48 PM Form 144 Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Jul 1, 2026 07:27 AM Unicycive Therapeutics (UNCY) PT Lowered to $13 at Benchmark on OLC Rejection
Jun 30, 2026 10:46 AM Increasing unusual option volume: UNM CGNX UNCY CNXC NN DOMO JACK SOLS KSTR
Jun 30, 2026 07:05 AM FDA issues second complete response letter to Unicycive over OLC drug application
Jun 30, 2026 07:05 AM Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)
Jun 29, 2026 07:09 AM H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Jun 22, 2026 06:07 AM Form DEFA14A Unicycive Therapeutics,
Jun 22, 2026 06:06 AM Form 8-K Unicycive Therapeutics, For: Jun 19
Jun 16, 2026 06:03 AM Form EFFECT Unicycive Therapeutics,
Jun 15, 2026 05:25 PM Form 4/A Unicycive Therapeutics, For: May 14 Filed by: Gupta Shalabh K.
View All Articles

Entities mentioned with UNCY

View All Entities